1. |
- Shah, Syed Muhammad Ismail, et al.
(författare)
-
COVID‐19 and myasthenia gravis : A review of neurological implications of the SARS‐COV‐2
- 2022
-
Ingår i: Brain and Behavior. - : Wiley. - 2162-3279. ; 12:12
-
Forskningsöversikt (refereegranskat)abstract
- IntroductionThis review highlights the potential mechanisms of neuromuscular manifestation of COVID-19, especially myasthenia gravis (MG).MethodsAn extensive literature search was conducted by two independent investigators using PubMed/MEDLINE and Google Scholar from its inception to December 2020.ResultsExacerbations of clinical symptoms in patients of MG who were treated with some commonly used COVID-19 drugs has been reported, with updated recommendations of management of symptoms of neuromuscular disorders. Severe acute respiratory syndrome coronavirus 2 can induce the immune response to trigger autoimmune neurological disorders.ConclusionsFurther clinical studies are warranted to indicate and rather confirm if MG in the setting of COVID-19 can pre-existent subclinically or develop as a new-onset disease.
|
|